Two Sigma Advisers’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $345K | Sell |
566,039
-56,800
| -9% | -$34.6K | ﹤0.01% | 1907 |
|
|
2025
Q1 | $470K | Sell |
622,839
-171,200
| -22% | -$129K | ﹤0.01% | 1804 |
|
|
2024
Q4 | $764K | Buy |
794,039
+87,400
| +12% | +$84.1K | ﹤0.01% | 1587 |
|
|
2024
Q3 | $1.02M | Buy |
706,639
+101,500
| +17% | +$146K | ﹤0.01% | 1405 |
|
|
2024
Q2 | $732K | Buy |
605,139
+99,100
| +20% | +$120K | ﹤0.01% | 1718 |
|
|
2024
Q1 | $1.19M | Sell |
506,039
-14,000
| -3% | -$32.9K | ﹤0.01% | 1494 |
|
|
2023
Q4 | $983K | Buy |
520,039
+133,343
| +34% | +$252K | ﹤0.01% | 1657 |
|
|
2023
Q3 | $530K | Buy |
386,696
+281,900
| +269% | +$386K | ﹤0.01% | 1773 |
|
|
2023
Q2 | $255K | Buy |
104,796
+12,500
| +14% | +$30.4K | ﹤0.01% | 2032 |
|
|
2023
Q1 | $532K | Sell |
92,296
-89,000
| -49% | -$513K | ﹤0.01% | 1921 |
|
|
2022
Q4 | $1.62M | Sell |
181,296
-29,400
| -14% | -$263K | ﹤0.01% | 1344 |
|
|
2022
Q3 | $3M | Sell |
210,696
-76,800
| -27% | -$1.09M | 0.01% | 979 |
|
|
2022
Q2 | $4.2M | Buy |
287,496
+11,600
| +4% | +$169K | 0.01% | 855 |
|
|
2022
Q1 | $5.51M | Buy |
275,896
+46,200
| +20% | +$923K | 0.01% | 764 |
|
|
2021
Q4 | $4.02M | Buy |
229,696
+158,615
| +223% | +$2.77M | 0.01% | 863 |
|
|
2021
Q3 | $557K | Sell |
71,081
-38,500
| -35% | -$302K | ﹤0.01% | 1883 |
|
|
2021
Q2 | $1.13M | Buy |
109,581
+33,200
| +43% | +$342K | ﹤0.01% | 1582 |
|
|
2021
Q1 | $999K | Buy |
76,381
+46,400
| +155% | +$607K | ﹤0.01% | 1651 |
|
|
2020
Q4 | $421K | Sell |
29,981
-10,585
| -26% | -$149K | ﹤0.01% | 1929 |
|
|
2020
Q3 | $482K | Buy |
40,566
+237
| +0.6% | +$2.82K | ﹤0.01% | 1840 |
|
|
2020
Q2 | $607K | Buy |
40,329
+2,172
| +6% | +$32.7K | ﹤0.01% | 1801 |
|
|
2020
Q1 | $275K | Buy |
+38,157
| New | +$275K | ﹤0.01% | 2049 |
|